Michael A. Treska

Partner
Orange County
  • 650 Town Center Drive
  • 20th Floor
  • Costa Mesa, CA 92626-1925
  • USA
Profile Experience

Michael Treska is the Managing Partner of Latham & Watkins' Orange County office. He advises clients on mergers and acquisitions, capital markets, and general corporate counseling.

Mr. Treska serves as primary outside counsel to several public and private companies in various industries, including healthcare, gaming, technology, and real estate. His practice focuses on mergers and acquisitions, corporate governance, and capital markets, and he has led the firm’s representation on numerous high profile and complex transactions. Supplementing his client work, Mr. Treska has served on the firm's Associates, Finance, and Recruiting Committees.

Prior to joining Latham, Mr. Treska practiced in the tax department of Deloitte & Touche LLP and is a Certified Public Accountant (inactive).

 Mr. Treska's representative transactions include:

  • Playtika in its US$2.2 billion IPO
  • William Lyon Homes in its US$2.4 billion sale to Taylor Morrison Home Corporation
  • Advantage Solutions in its US$5.2 billion business combination with Conyers Park II Acquisition Corp.
  • PDL BioPharma in its US$52.8 million divestiture of the Noden Pharmaceutical business to Stanley Capital
  • Golden State Foods in its sale of nine distribution centers to The Martin-Brower Company
  • Playtika in its acquisition of Seriously Holding Corp.
  • Playtika in its acquisition of Wooga, a Germany-based developer of online mobile game applications
  • Allergan in the US$53 billion hostile takeover attempt by Valeant Pharmaceuticals International and Pershing Square
  • Allergan in its US$73 billion sale to Actavis
  • Impact Biomedicines in its US$7 billion acquisition by Celgene Corporation
  • Capella Education Company in its US$1.9 billion merger with Strayer Education, Inc.
  • NYX Gaming in its US$631 million acquisition by Scientific Gaming
  • Caesars Interactive Entertainment in its US$4.4 billion sale of its social and mobile games business, Playtika, to a consortium that includes an affiliate of Chinese online game maker Shanghai Giant Network Technology Co., Ltd.
  • Thoratec in its US$3.4 billion acquisition by St. Jude Medical
  • 5.11 Tactical in its US$400 million sale to Compass Diversified Holdings
  • QSI in its US$190 million acquisition of Health Fusion Holdings    
  • William Lyon Homes in its US$520 million acquisition of Polygon Northwest Homes
  • Fox Head in its US$195 million sale to Altamont Capital Partners
  • William Lyon Homes in its US$250 million IPO and in several high yield and equity offerings
  • Tilly’s in connection with its IPO -Tilly's IPO was listed on Daily Journal's “Top 10 California IPOs of 2012
  • Goldman, Sachs & Co., in the US$7 billion acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb
  • Quest Software in its US$2.4 billion acquisition by Dell
  • Beckman Coulter, Inc. in its US$6.8 billion sale to Danaher
  • Volcom in its US$600 million sale to PPR S.A.    
  • Allergan, Inc. in its acquisition of Vicept Therapeutics
  • Caesars Entertainment in its acquisition of a majority interest in Playtika Ltd., an Israeli social game developer
  • Beckman Coulter, Inc. in its ¥76 billion acquisition of a Japanese lab based diagnostic system  
  • Harrah’s Entertainment, Inc. in its US$27.8 billion sale to affiliates of Texas Pacific Group and Apollo Management, L.P.    
  • Skilled Healthcare Group in connection with its IPO and its US$200 million senior subordinated notes offering
  • Oakley, Inc. in its acquisitions of Oliver Peoples, Inc., Optical Shop of Aspen and Eye Safety Systems, Inc.
  • Harrah’s Entertainment, Inc. in its acquisition of Caesars Entertainment, Inc. and its issuance of US$3 billion of senior notes
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.